RIKEN researchers have developed a promising method to deliver a drug to cancer cells without affecting surrounding tissues, involving a clever combination of an artificial metalloenzyme that protects a metal catalyst, and a sugar chain that guides the metalloenzyme to the desired cells.
Click here for original story, New metalloenzyme-based system allows selective targeting of cancer cells
Source: Phys.org